Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$17.06M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$1.5M$3.0M2026 · bought $0 · sold $3.0M2026
Total +$0.0000 bought · $2.99M sold

All filings on record

Every Form 4 transaction we track for this filer

RXRXGrant
2026-06-17 · RECURSION PHARMACEUTICALS, INC.
88,424
MRKSell
2026-02-10 · Merck & Co., Inc.
$1.20M
MRKSell
2026-02-04 · Merck & Co., Inc.
$1.79M
MRKExercise
2026-02-04 · Merck & Co., Inc.
$845.5K
MRKGrant
2026-01-26 · Merck & Co., Inc.
$2.20M
RXRXGrant
2026-01-02 · RECURSION PHARMACEUTICALS, INC.
2,381
RXRXGrant
2025-10-01 · RECURSION PHARMACEUTICALS, INC.
1,961
RXRXGrant
2025-07-01 · RECURSION PHARMACEUTICALS, INC.
1,949
RXRXGrant
2025-06-18 · RECURSION PHARMACEUTICALS, INC.
22,016

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.